Jessica J. Kandel to Treatment Outcome
This is a "connection" page, showing publications Jessica J. Kandel has written about Treatment Outcome.
Connection Strength
0.144
-
Management of lymphatic malformations in children. Curr Opin Pediatr. 2015 Jun; 27(3):356-63.
Score: 0.054
-
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. J Pediatr Surg. 2001 Aug; 36(8):1177-81.
Score: 0.021
-
Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg. 2001 Aug; 36(8):1273-6.
Score: 0.021
-
Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors. J Pediatr Surg. 2001 Feb; 36(2):357-61.
Score: 0.020
-
Initial Experience With Propranolol Treatment of Lymphatic Anomalies: A Case Series. Pediatrics. 2016 09; 138(3).
Score: 0.015
-
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.
Score: 0.008
-
All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. J Pediatr Surg. 2001 Feb; 36(2):287-90.
Score: 0.005